Clinical Trials
3 trialsNCT04106219 2026-04-21
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
Eli Lilly and Company
Phase 1 Active not recruiting
NCT07165262 2025-09-10
ECOG-Anaes
Children's Cancer Hospital Egypt 57357
Phase 3 Active not recruiting
NCT05029960 2024-08-09
Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas
University of Rochester
Phase EARLY_PHASE1 Active not recruiting